|
stage, non-small cell lung cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Herein, we investigated the associations between clinicopathological parameters and VIM/E-cad expression in primary T1 stage non-small cell lung cancer (NSCLC).
|
28592120 |
2019 |
|
Acantholytic squamous cell carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Several cases of oral ASCC also expressed vimentin and cytokeratin (CK) 19, markers associated with epithelial-mesenchymal transition.
|
31706621 |
2019 |
|
Malignant mesenchymal tumor
|
0.010 |
Biomarker
|
disease |
BEFREE |
On histopathology, we found malignant mesenchymal tumor positive for vimentin and cluster of differentiation 10 (CD10).
|
31523571 |
2019 |
|
Carcinoma ex pleomorphic adenoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
To investigate C-myc, Ki-67, pan-cytokeratin, and vimentin immunohistochemical features of carcinoma ex pleomorphic adenoma (Ca-ex-PA) and pleomorphic adenoma (PA) in the lacrimal gland in order to find some clues in the differential diagnosis between them.
|
31456912 |
2019 |
|
Corneal fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Prior findings have revealed vimentin-deficient mice are significantly protected from corneal fibrosis after alkali injury, which has implicated this IF protein as an important regulator of corneal fibrosis.
|
30590024 |
2019 |
|
Tongue Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
UCA1 knockdown significantly suppressed TGFβ1-induced tongue cancer cell invasion and EMT by decreasing vimentin and increasing E-cadherin.
|
30635938 |
2019 |
|
Primary sclerosing cholangitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The aim of this study is to evaluate the role of vimentin in the progression of biliary damage/liver fibrosis and whether there is a mesenchymal phenotype of cholangiocytes in the Mdr2<sup>-/-</sup> model of PSC.
|
31522982 |
2019 |
|
Tumor Initiation
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
The ZnAs@SiO<sub>2</sub> NPs also inhibited tumor spheroid formation <i>in vitro</i> and tumor initiation <i>in vivo</i> and induced significant changes in the expression of stemness markers (CD133, Sox-2, and Oct-4) and EMT markers (E-cadherin, Vimentin, and Slug) both <i>in vitro</i> and <i>in vivo.</i> These effects of ZnAs@SiO<sub>2</sub> that correlated with prognosis of HCC were mediated by the SHP-1/JAK2/STAT3 signaling.
|
31285768 |
2019 |
|
Pelvic Organ Prolapse
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to explore the link between autophagy and collagen metabolism in patients with pelvic organ prolapse (POP) by detecting the expressions of autophagy factors, collagen, desmin, cytokeratin, and vimentin.
|
28786871 |
2019 |
|
Gestational Trophoblastic Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Trophoblastic cells did not express vimentin, and the expression of E-cadherin was maintained in all cases, indicating the absence of EMT features in GTN.
|
30847562 |
2019 |
|
Myofibroma (morphologic abnormality)
|
0.010 |
Biomarker
|
disease |
BEFREE |
Using a tissue microarray technique (TMA), cases of myofibroma (MF), of nodular fasciitis (NF), of desmoplastic fibroma (DF), and of myofibroblastic sarcoma (MS) from the Universidad Autónoma Metropolitana Xochimilco, and a Private Oral Pathology Service in Mexico City were stained with antibodies against alpha-smooth muscle actin (α-SMA), H-caldesmon, vimentin, desmin, β-catenin, CD34, anaplastic lymphoma protein kinase (ALK-1), and Ki-67.
|
30168888 |
2019 |
|
Stage IA Lung Adenocarcinoma AJCC v7
|
0.010 |
Biomarker
|
disease |
BEFREE |
We conducted immunohistochemical analysis of the expression of the EMT markers E-cadherin and vimentin of specimens acquired from 183 consecutive patients with stage IA lung adenocarcinoma.
|
31103348 |
2019 |
|
Solitary Myofibromatosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Using a tissue microarray technique (TMA), cases of myofibroma (MF), of nodular fasciitis (NF), of desmoplastic fibroma (DF), and of myofibroblastic sarcoma (MS) from the Universidad Autónoma Metropolitana Xochimilco, and a Private Oral Pathology Service in Mexico City were stained with antibodies against alpha-smooth muscle actin (α-SMA), H-caldesmon, vimentin, desmin, β-catenin, CD34, anaplastic lymphoma protein kinase (ALK-1), and Ki-67.
|
30168888 |
2019 |
|
Cardiac fibrosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Flow cytometry analysis was performed to identify cardiac fibroblasts by examining vimentin, fibronectin (FN) and α-actin expression in human CFs. qRT-PCR and western blot assays were performed to confirm the expression of miR-32-5p, DUSP1 and cardiac fibrosis relevant proteins.
|
31438862 |
2019 |
|
Tumor-Associated Vasculature
|
0.010 |
Biomarker
|
disease |
BEFREE |
The native tropism of CPMV for cell-surface displayed vimentin and the enhanced permeability and retention effect allow them to preferentially extravasate from tumor neovasculature and efficiently penetrate tumors.
|
31004625 |
2019 |
|
Benign Prostatic Hyperplasia
|
0.010 |
Biomarker
|
disease |
BEFREE |
We isolated and cultured vimentin-positive prostate stromal cells obtained from BPH patients.
|
31730867 |
2019 |
|
Papillary Thyroid Microcarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunohistochemical staining for Laminin Subunit Gamma 2 (LAMC2), CD59, E-cadherin, and vimentin showed that these markers of EMT were associated with progressive changes in E-margin PTMC-mETE(-), I-margin PTMC-mETE(-), and pPTMC-mETE(+).
|
31146263 |
2019 |
|
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, silencing ELFN1-AS1 significantly reduced the activation of extracellular signal-regulated protein kinase (Erk), up-regulated the protein expression of E-cadherin and down-regulated vimentin.
|
31814902 |
2019 |
|
Group B Streptococcal Infection
|
0.010 |
Biomarker
|
disease |
BEFREE |
Vimentin null mice were protected from WT GBS infection and also exhibited less inflammatory cytokine production in brain tissue.
|
31181121 |
2019 |
|
Gastrointestinal Mixed Adenoneuroendocrine Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The clinicopathological features of 13 consecutive cases of MANEC (6 gastric and 7 colorectal) were correlated with the IHC expression of the biomarkers E-cadherin, β-catenin, N-cadherin, vimentin, maspin, CD44 and S100.
|
31704155 |
2019 |
|
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D
|
0.010 |
Biomarker
|
disease |
BEFREE |
An immunohistochemical method was used to detect MTDH expression and the epithelial-mesenchymal transition markers E-cadherin and vimentin in 66 cases of PCCA.
|
30988817 |
2019 |
|
Axial spondyloarthritis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis.
|
30767876 |
2019 |
|
Early Inflammatory Arthritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The aim of the study was to evaluate the frequency of anti-mutated citrullinated vimentin antibodies (a-Sa), anti-citrullinated α-enolase peptide 1 antibodies (a-CEP-1), anti-filaggrin antibodies (AFAs), heterogeneous nuclear ribonucleoprotein compies/anti-RA33-antibodies (a-hnRNP/RA33), anti-carbamylated protein antibodies (a-CarP), and metalloproteinase (MMPs) activity in patients with early inflammatory arthritis (EIA).
|
30406565 |
2019 |
|
Guillain-Barre Syndrome, Familial
|
0.010 |
Biomarker
|
disease |
BEFREE |
Vimentin null mice were protected from WT GBS infection and also exhibited less inflammatory cytokine production in brain tissue.
|
31181121 |
2019 |
|
Non-squamous non-small cell lung cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
The aim of the present study was to assess the expression of epithelial-mesenchymal transition biomarkers (E-cadherin and vimentin) and their potential significance as prognostic markers in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) enrolled in the INNOVATIONS trial, receiving treatment with either erlotinib/bevacizumab (EB) or cisplatin/gemcitabine/bevacizumab (PGB).
|
31186697 |
2019 |